| 2026-03-03 |
详情>>
内部人交易：
Akkerman Michael股份减少28965.00股
|
| 2026-02-03 |
详情>>
股本变动：
变动后总股本11989.99万股
|
| 2026-02-03 |
详情>>
业绩披露：
2026年三季报(累计)每股收益-0.27美元,归母净利润-3039.2万美元,同比去年增长58.52%
|
| 2026-02-03 |
财报披露：
美东时间 2026-02-03 盘后发布财报
|
| 2025-11-04 |
详情>>
业绩披露：
2026年中报每股收益-0.33美元,归母净利润-3549.9万美元,同比去年增长29.20%
|
| 2025-08-05 |
详情>>
业绩披露：
2026年一季报每股收益-0.13美元,归母净利润-1410.4万美元,同比去年增长43.93%
|
| 2025-07-17 |
股东大会：
将于2025-08-26召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying Proxy Statement to serve on our Board of Directors for a one-year term that expires at our 2026 annual meeting of stockholders;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026;
4.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2025-06-16 |
详情>>
业绩披露：
2025年年报每股收益-0.89美元,归母净利润-9209.9万美元,同比去年增长78.08%
|
| 2025-06-16 |
详情>>
业绩披露：
2023年年报每股收益0.17美元,归母净利润1667.30万美元,同比去年增长-53.09%
|
| 2025-02-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.71美元,归母净利润-7327.3万美元,同比去年增长60.12%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年中报每股收益-1.69美元,归母净利润-1.7亿美元,同比去年增长-738.16%
|
| 2024-11-06 |
详情>>
业绩披露：
2025年中报每股收益-0.49美元,归母净利润-5014.2万美元,同比去年增长70.45%
|
| 2024-08-07 |
详情>>
业绩披露：
2025年一季报每股收益-0.25美元,归母净利润-2515.6万美元,同比去年增长-207.57%
|
| 2024-07-15 |
股东大会：
将于2024-08-27召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying Proxy Statement to serve on our Board of Directors for a one-year term that expires at our 2025 annual meeting of stockholders;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025;
4.To approve an amendment to our 2020 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,560,000 shares, from 12,000,0000 shares to 20,560,000 shares, and make certain other changes;
5.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2024-05-28 |
详情>>
业绩披露：
2024年年报每股收益-4.16美元,归母净利润-4.2亿美元,同比去年增长-2620.41%
|
| 2024-02-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.83美元,归母净利润-1.84亿美元,同比去年增长-700.3%
|
| 2023-07-18 |
股东大会：
将于2023-08-29召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying Proxy Statement to serve on our Board of Directors for a one-year term that expires at our 2024 annual meeting of stockholders;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of Grant Thornton LLP (“Grant Thornton”) as our independent registered public accounting firm for the fiscal year ending March 31, 2024;
4.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2022-07-15 |
股东大会：
将于2022-08-30召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying Proxy Statement to serve on our Board of Directors for a one-year term that expires at our 2023 annual meeting of stockholders;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of Grant Thornton LLP (“Grant Thornton”) as our independent registered public accounting firm for the fiscal year ending March 31, 2023;
4.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-29 |
股东大会：
将于2021-09-14召开股东大会
会议内容 ▼▲
- 1.To elect the seven (7) director nominees named in the accompanying Proxy Statement to serve on our Board of Directors for a one-year term ending as of our annual meeting of stockholders in fiscal year 2023;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of Grant Thornton LLP (“Grant Thornton”) as our independent registered public accounting firm for the fiscal year ending March 31, 2022;
4.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2020-07-29 |
股东大会：
将于2020-09-15召开股东大会
会议内容 ▼▲
- 1.To elect the seven (7) director nominees named in the accompanying Proxy Statement to serve on our board of directors for a one-year term ending as of our Annual Meeting of stockholders in fiscal year 2022;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To approve, in a non-binding advisory vote, the frequency of future advisory ("say-on-pay") votes on executive compensation;
4.To approve our 2020 Equity Incentive Plan;
5.To ratify the appointment of SingerLewak LLP ("SingerLewak") as our independent registered public accounting firm for the fiscal year ending March 31, 2021;
6.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2019-07-29 |
股东大会：
将于2019-09-17召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve on our board of directors for a one-year term ending as of our Annual Meeting of stockholders in fiscal year 2021;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of SingerLewak LLP ("SingerLewak") as our independent registered public accounting firm for the fiscal year ending March 31, 2020;
4.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2018-07-30 |
股东大会：
将于2018-09-19召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve on our board of directors for a one-year term ending as of our Annual Meeting of stockholders in fiscal year 2020;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of SingerLewak LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2019; 4.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2017-12-21 |
股东大会：
将于2018-01-19召开股东大会
会议内容 ▼▲
- 1.To elect six (6) directors to serve on our board of directors for a one-year term ending as of our Annual Meeting of stockholders in fiscal year 2019;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To approve the issuance of shares of our common stock issuable upon the conversion of 8.75% Convertible Senior Notes due 2020 and exercise of warrants issued in a private placement transaction in September 2016, as amended and supplemented in January and May 2017, in accordance with NASDAQ Marketplace Rules 5635(b) and 5635(d);
4.To ratify the appointment of SingerLewak LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2018; 5.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2016-11-25 |
股东大会：
将于2017-01-10召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve on our board of directors for a one-year term ending as of our Annual Meeting of stockholders in fiscal year 2018;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To approve, in accordance with NASDAQ Marketplace Rules 5635(b) and 5635(d), the issuance of shares of our common stock issuable upon the conversion of 8.75% Convertible Senior Notes due 2020 and exercise of warrants issued in a private placement transaction in September 2016 ;
4.To approve an amendment of our restated certificate of incorporation, as amended, to effect a reverse stock split of our common stock at a ratio to be determined by our board of directors within a specified range and a related reduction in the authorized number of shares of our common stock, except in the case of a one-for-two reverse split ratio;
5.To ratify the appointment of SingerLewak LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2017;
6.To transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2016-02-11 |
股东大会：
将于2016-03-09召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on our board of directors for a one-year term ending as of our annual meeting of stockholders in fiscal year 2017;
2.To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as “Say-on-pay”;
3.To ratify the appointment of SingerLewak LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2016;
4.Transact such other business as may properly come before the meeting and/or any adjournment or postponement thereof.
|
| 2014-11-14 |
复牌提示：
2014-11-13 16:00:35 停牌，复牌日期 2014-11-13 16:35:00
|